Clinical trials
Pulmonary Nodules clinical trials
Below are recruiting pulmonary nodules clinical trials, each written for real people, not researchers. We’re tracking 37 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06923774Recruiting
Registry study for lung biopsy with Ion system
This study collects information from patients having a lung biopsy or nodule localization using the Ion endoluminal system. It aims to understand how well the system works in real-world settings.
Le Plessis-RobinsonAges 18 years+ - NCT04478292RecruitingPhase 3
New treatment strategy for children with newly diagnosed liver cancer
This Phase 3 study tests a modified treatment plan for children newly diagnosed with hepatoblastoma, a type of liver cancer. It may help improve how well treatment works and how safely it can be given by using a structured approach.
Shanghai, Shanghai MunicipalityAges Up to 18 years - NCT05306912Recruiting
Test gene analysis on liquid from a lung biopsy
This study looks at special lab tests (molecular analysis) done on liquid taken during a bronchoscopy to better understand lung nodules. It may help doctors learn more about what these nodules are, using samples from the procedure.
Toulouse, OccitanieAges 18 years+ - NCT06628102Recruiting
Breath test for early lung cancer detection
This study tests a breath test to detect lung cancer early in people with a lung nodule found on a CT scan. It aims to improve detection in diverse populations.
Vancouver, British ColumbiaAges 50–80 - NCT06889467Recruiting
Testing leftover fluid from lymph node biopsies to find lung cancer
This trial is for people who are scheduled for a lung cancer biopsy (EBUS-TBNA) because doctors suspect non-small cell lung cancer (NSCLC) has spread to lymph nodes. It will test leftover fluid from the biopsy to see if it improves cancer detection. If your biopsy is negative but you still need surgery to remove lymph nodes, you can help us learn more about this new test.
AshkelonAges 18 years+ - NCT06924398RecruitingPhase 2
Post-surgery targeted therapy for remaining lung nodules in EGFR-mutant NSCLC
This trial tests whether a targeted therapy pill (EGFR-TKI) can control small spots in the other lung after surgery for early-stage lung cancer. It's for people whose cancer has a specific EGFR gene change and who still have suspicious spots in the opposite lung after one side is removed.
Guangzhou, GuangdongAges 18–75 - NCT06950515Recruiting
Anesthesia vs sedation for lung nodule biopsy
This trial compares general anesthesia with conscious sedation during a special ultrasound-guided lung biopsy. It aims to find which approach is safer and more comfortable for diagnosing small lung lesions.
Québec, QuebecAges 18 years+ - NCT07153263Recruiting
Testing a new numbing shot for lung nodule localization
This study tests a new type of numbing injection (called a retro-superior costotransverse ligament space block) to see how well it spreads and numbs the area during CT-guided lung nodule localization. The goal is to find better ways to keep you comfortable during the procedure.
Nanjing, JiangsuAges 18–80 - NCT07322796Recruiting
Quit smoking before lung biopsy
This trial tests whether helping people quit smoking before a lung biopsy (bronchoscopy or CT-guided needle) improves the procedure or reduces complications. If you smoke and have a suspicious lung nodule, this study may help you quit while getting the care you need.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT07370077Recruiting
Early screening for lung nodules with breath, blood, and CT scans
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07487883Recruiting
PET scan for lung cancer using a special tracer
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
Beijing, Beijing MunicipalityAges 18 years+ - NCT03774758Recruiting
Blood tests to estimate lung cancer risk over 3 years
This study looks for blood “biomarkers” (measurable signs in blood) that may help predict who is at higher or lower risk related to lung cancer. You would have blood samples taken and then be followed with visits for up to 3 years.
San Francisco, CaliforniaAges 40 years+ - NCT07180823Recruiting
Lung nodule tagging before surgery using a navigation system
This trial uses a special navigation system to place tiny markers next to lung nodules before surgery. This helps surgeons find and remove the nodule more precisely.
Bologna, BolognaAges 18 years+
Hear when a new Pulmonary Nodules trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary nodules?
- Yes. Clin2 currently lists 37 recruiting pulmonary nodules studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary nodules trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary nodules trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.